# Alitretinoin in the Treatment of Chronic Hand Eczema

> **NCT00519675** · PHASE3 · COMPLETED · sponsor: **Basilea Pharmaceutica** · enrollment: 150 (estimated)

## Conditions studied

- Eczema

## Interventions

- **DRUG:** alitretinoin

## Key facts

- **NCT ID:** NCT00519675
- **Lead sponsor:** Basilea Pharmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519675, "Alitretinoin in the Treatment of Chronic Hand Eczema". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00519675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*